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PRACTICAL PEARLS:  C. difficile infection (CDI) 
 
INTRODUCTION  Caused by the stool bacteria Clostridium difficile 
 Increasing incidence in pediatrics over the past 15-20 years 
 Presenting symptoms: watery diarrhea (with or without blood), crampy abdominal pain, 




BY PRIMARY CARE 
 Risk factors for pediatric CDI: antibiotic use within the past 30 days, current/recent 
inpatient hospitalization > 7 days, recent bowel surgery/GI tract manipulation (including 
prolonged NG tube insertion, tube feedings, and gastrostomy tube presence), immune 
suppression, exposure to those infected and/or colonized with C. difficile 
 Consider obtaining stool testing from children older than 12 months with suspicious 
clinical symptoms  and  > 1 risk factors for CDI 
 Testing is not recommended for children  < 12 months, due to high rates of 
asymptomatic C. difficile carriage in this age group 
 Oral metronidazole – initial treatment for mild-to-moderate disease, while oral 
vancomycin – initial therapy for severe disease, or for those who do not respond to 
metronidazole 
 
AAP Policy statement on pediatric CDI: 






WHEN TO REFER  Questions about appropriate indications for testing, alternative diagnoses, optimal 
antibiotic selection and duration of treatment 
 Previously treated patients with refractory or recurrent CDI  
 
HOW TO REFER  794-KIDS – Request Pediatric Infectious Diseases appointments  
 For more urgent access, please call the Pedi ID doctor on call 
 




 Current patient information and pertinent  medical records from the primary care office 
will be requested prior to the visit for review 
 Due to the nature of some patients’ symptoms, other referrals such as gastroenterology, 
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